Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, Körbling M, Martin T, Ueno NT, Champlin RE, Khouri IF. Hosing C, et al. Among authors: yazji s. Ann Oncol. 2002 Mar;13(3):450-9. doi: 10.1093/annonc/mdf109. Ann Oncol. 2002. PMID: 11996478 Free article.
Impact of high-dose chemotherapy on peripheral T-cell lymphomas.
Rodriguez J, Munsell M, Yazji S, Hagemeister FB, Younes A, Andersson B, Giralt S, Gajewski J, de Lima M, Couriel D, Romaguera J, Cabanillas FF, Champlin RE, Khouri IF. Rodriguez J, et al. Among authors: yazji s. J Clin Oncol. 2001 Sep 1;19(17):3766-70. doi: 10.1200/JCO.2001.19.17.3766. J Clin Oncol. 2001. PMID: 11533100
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.
Reichardt P, Blay JY, Gelderblom H, Schlemmer M, Demetri GD, Bui-Nguyen B, McArthur GA, Yazji S, Hsu Y, Galetic I, Rutkowski P. Reichardt P, et al. Among authors: yazji s. Ann Oncol. 2012 Jul;23(7):1680-7. doi: 10.1093/annonc/mdr598. Epub 2012 Feb 21. Ann Oncol. 2012. PMID: 22357255 Free article. Clinical Trial.
Iseganan HCl: a novel antimicrobial agent.
Giles FJ, Redman R, Yazji S, Bellm L. Giles FJ, et al. Among authors: yazji s. Expert Opin Investig Drugs. 2002 Aug;11(8):1161-70. doi: 10.1517/13543784.11.8.1161. Expert Opin Investig Drugs. 2002. PMID: 12150709 Review.
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors.
Rosen LS, LoRusso P, Ma WW, Goldman JW, Weise A, Colevas AD, Adjei A, Yazji S, Shen A, Johnston S, Hsieh HJ, Chan IT, Sikic BI. Rosen LS, et al. Among authors: yazji s. Invest New Drugs. 2016 Oct;34(5):604-13. doi: 10.1007/s10637-016-0374-3. Epub 2016 Jul 16. Invest New Drugs. 2016. PMID: 27424159 Free PMC article. Clinical Trial.
Pressure dependence of Raman spectrum in InAs nanowires.
Yazji S, Zardo I, Hertenberger S, Morkötter S, Koblmüller G, Abstreiter G, Postorino P. Yazji S, et al. J Phys Condens Matter. 2014 Jun 11;26(23):235301. doi: 10.1088/0953-8984/26/23/235301. J Phys Condens Matter. 2014. PMID: 25932470
14 results